Aquestive Therapeutics, Inc. (AQST) SEC Filings — 2025
20 SEC filings for Aquestive Therapeutics, Inc. (AQST) in 2025.
Filings
- Aquestive Therapeutics Files 8-K — 8-K · Nov 6, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Nov 5, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Oct 8, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Oct 1, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Sep 8, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Sep 4, 2025
- Aquestive Therapeutics Files 8-K for Material Agreement — 8-K · Aug 15, 2025
- Aquestive Therapeutics Enters Material Definitive Agreement — 8-K · Aug 14, 2025
- Aquestive's Q2 Loss Widens to $20.2M Amid Rising Costs — 10-Q · Aug 11, 2025
- Aquestive Therapeutics Files Routine 8-K — 8-K · Jul 15, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Jun 16, 2025
- Aquestive Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 11, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Jun 2, 2025
- Aquestive Therapeutics Q1 2025 10-Q Filed — 10-Q · May 12, 2025
- Aquestive Therapeutics Files Proxy Statement for 2025 Annual Meeting — DEF 14A · Apr 25, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Apr 1, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Mar 10, 2025
- Aquestive Therapeutics Files 2024 10-K — 10-K · Mar 5, 2025
- Aquestive Therapeutics Files 8-K — 8-K · Feb 12, 2025
- Aquestive Therapeutics Files 8-K on Financials — 8-K · Jan 13, 2025